You have 9 free searches left this month | for more free features.

cetuximab

Showing 1 - 25 of 558

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • Crisaborole Ointment
  • Cetuximab
  • Guangzhou, Guangdong, China
    WeiWei Xiao
Nov 3, 2023

Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2023

Colorectal Cancer Liver Metastases Trial in Shanghai (Cetuximab)

Not yet recruiting
  • Colorectal Cancer Liver Metastases
  • Cetuximab
  • Shanghai, Shanghai, China
  • +1 more
May 22, 2023

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

Not yet recruiting
  • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
  • Cetuximab
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Oct 24, 2023

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

Not yet recruiting
  • Head Neck
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Center
Sep 14, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

Advance NSCLC Trial (GFH925, Cetuximab)

Not yet recruiting
  • Advance Non-small Cell Lung Cancer
  • (no location specified)
Mar 7, 2023

Cancer of Colon Trial in Jerusalem (Cetuximab)

Terminated
  • Cancer of Colon
  • Cetuximab
  • Jerusalem, Israel
    Hadassah Ein Kerem
Aug 2, 2022

Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023

Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)

Not yet recruiting
  • Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 20, 2023

Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

Not yet recruiting
  • Colon Adenocarcinoma
  • +4 more
  • (no location specified)
Jan 24, 2023

Colorectal Cancer Trial (SOT101, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Dec 5, 2022

Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)

Not yet recruiting
  • Colon Cancer
  • Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Apr 24, 2023

Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Non-Small Cell Lung Cancer
  • (no location specified)
Jul 12, 2023

Metastatic Colorectal Cancer Trial (ZN-c3, Encorafenib, Cetuximab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Feb 15, 2023

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Cetuximab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 4, 2022

Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)

Recruiting
  • Squamous Cell Cancers of the Head and Neck
  • New Haven, Connecticut
    Yale Cancer Center
Jan 10, 2023

Recurrent Head Neck Cancer, Head Neck Cancer, Head and Neck Tumors Trial in Cincinnati (Durvalumab, Cetuximab)

Active, not recruiting
  • Recurrent Head and Neck Cancer
  • +3 more
  • Cincinnati, Ohio
    UC Health
Oct 3, 2022

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in United States (Cetuximab, PD 0332991)

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Cetuximab
  • PD 0332991
  • Atlanta, Georgia
  • +4 more
Nov 1, 2022

Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)

Active, not recruiting
  • Head and Neck Cancer
  • Locally Advanced
  • Bangkok, Thailand
    Faculty of Medicine, Ramathibodi Hospital
Sep 19, 2022